Literature DB >> 26817032

Efficacy of Herpes Simplex Virus Vector Encoding the Human Preproenkephalin Gene for Treatment of Facial Pain in Mice.

Fei Ma, Chunmei Wang, William E Yoder, Karin N Westlund, Charles R Carlson, Craig S Miller, Robert J Danaher.   

Abstract

AIMS: To determine whether herpes simplex virus-based vectors can efficiently transduce mouse trigeminal ganglion (TG) neurons and attenuate preexisting nerve injury-induced whisker pad mechanical hypersensitivity in a trigeminal inflammatory compression (TIC) neuropathic pain model.
METHODS: Tissue transduction efficiencies of replication-conditional and replication-defective vectors to mouse whisker pads after topical administration and subcutaneous injection were assessed using quantitative real-time PCR (qPCR). Tissue tropism and transgene expression were assessed using qPCR and reverse-transcriptase qPCR following topical application of the vectors. Whisker pad mechanical sensitivities of TIC-injured mice were determined using graduated von Frey fibers before and after application of human preproenkephalin expressing replication-conditional vector (KHPE). Data were analyzed using one-way analysis of variance (ANOVA) and post hoc tests.
RESULTS: Transduction of target TGs was 8- to 50-fold greater after topical application than subcutaneous injection and ≥ 100-fold greater for replication-conditional than replication-defective vectors. Mean KHPE loads remained constant in TGs (4.5-9.8 × 10(4) copies/TG) over 3 weeks but were below quantifiable levels (10 copies/tissue) within 2 weeks of application in other nontarget cephalic tissues examined. Transgene expression in TGs was maximal during 2 weeks after topical application (100-200 cDNA copies/mL) and was below quantifiable levels (1 cDNA copy/mL) in all nontarget tissues. Topical KHPE administration reduced TIC-related mechanical hypersensitivity on whisker pads 4-fold (P < .05) for at least 1 week.
CONCLUSION: Topically administered KHPE produced a significant antinociceptive effect in the TIC mouse model of chronic facial neuropathic pain. This is the first report in which a gene therapeutic approach reduced trigeminal pain-related behaviors in an established pain state in mice.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26817032      PMCID: PMC4874570          DOI: 10.11607/ofph.1512

Source DB:  PubMed          Journal:  J Oral Facial Pain Headache


  34 in total

1.  Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion.

Authors:  J R Goss; M Mata; W F Goins; H H Wu; J C Glorioso; D J Fink
Journal:  Gene Ther       Date:  2001-04       Impact factor: 5.250

2.  Analysis of individual human trigeminal ganglia for latent herpes simplex virus type 1 and varicella-zoster virus nucleic acids using real-time PCR.

Authors:  R J Cohrs; J Randall; J Smith; D H Gilden; C Dabrowski; H van Der Keyl; R Tal-Singer
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Trigeminal ganglion infection by thymidine kinase-negative mutants of herpes simplex virus.

Authors:  R B Tenser; R L Miller; F Rapp
Journal:  Science       Date:  1979-08-31       Impact factor: 47.728

4.  Latency-associated transcript but not reactivatable virus is present in sensory ganglion neurons after inoculation of thymidine kinase-negative mutants of herpes simplex virus type 1.

Authors:  R B Tenser; K A Hay; W A Edris
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

5.  Replication of herpes simplex virus type 1 within trigeminal ganglia is required for high frequency but not high viral genome copy number latency.

Authors:  R L Thompson; N M Sawtell
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

Review 6.  Virally mediated delivery of enkephalin and other neuropeptide transgenes in experimental pain models.

Authors:  Steven P Wilson; David C Yeomans
Journal:  Ann N Y Acad Sci       Date:  2002-10       Impact factor: 5.691

Review 7.  Therapeutic gene transfer to the nervous system using viral vectors.

Authors:  Joseph C Glorioso; Marina Mata; David J Fink
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

8.  Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate.

Authors:  D M Coen; M Kosz-Vnenchak; J G Jacobson; D A Leib; C L Bogard; P A Schaffer; K L Tyler; D M Knipe
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

9.  Enhanced replication of herpes simplex virus type 1 in human cells.

Authors:  C S Miller; K O Smith
Journal:  J Dent Res       Date:  1991-02       Impact factor: 6.116

10.  Reversal of ongoing thermal hyperalgesia in mice by a recombinant herpesvirus that encodes human preproenkephalin.

Authors:  David C Yeomans; Toni Jones; Charles E Laurito; Ying Lu; Steven P Wilson
Journal:  Mol Ther       Date:  2004-01       Impact factor: 11.454

View more
  4 in total

1.  Overexpression of µ-Opioid Receptors in Peripheral Afferents, but Not in Combination with Enkephalin, Decreases Neuropathic Pain Behavior and Enhances Opioid Analgesia in Mouse.

Authors:  Amanda H Klein; Husam K Mohammad; Rabiah Ali; Brad Peper; Steven P Wilson; Srinivasa N Raja; Matthias Ringkamp; Sarah Sweitzer
Journal:  Anesthesiology       Date:  2018-05       Impact factor: 7.892

2.  Diabetic neuropathic pain induced by streptozotocin alters the expression profile of non-coding RNAs in the spinal cord of mice as determined by sequencing analysis.

Authors:  Jian He; Han Bin Wang; Jiang Ju Huang; Lei Zhang; Dong Lin Li; Wan You He; Qing Ming Xiong; Zai Sheng Qin
Journal:  Exp Ther Med       Date:  2021-05-18       Impact factor: 2.751

Review 3.  Gene Therapy: A Paradigm Shift in Dentistry.

Authors:  Nida Siddique; Hira Raza; Sehrish Ahmed; Zohaib Khurshid; Muhammad Sohail Zafar
Journal:  Genes (Basel)       Date:  2016-11-10       Impact factor: 4.096

4.  Histone deacetylase inhibitors prevent persistent hypersensitivity in an orofacial neuropathic pain model.

Authors:  Robert J Danaher; Liping Zhang; Connor J Donley; Nashwin A Laungani; S Elise Hui; Craig S Miller; Karin N Westlund
Journal:  Mol Pain       Date:  2018 Jan-Dec       Impact factor: 3.395

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.